 Equities analysts expect that Eiger Biopharmaceuticals Inc NASDAQ:EIGR will announce earnings per share EPS of 0.85 for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Eiger Biopharmaceuticals earnings, with estimates ranging from 1.10 to 0.70. Eiger Biopharmaceuticals posted earnings of 0.90 per share in the same quarter last year, which ... 